Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of peri-operative testosterone levels on functional and oncological outcomes following radical prostatectomy
2020-003012-27Phase 3Active
- Sponsor
- Canisius-Wilhelmina Hospital
- Start
- Aug 2020
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Hypogonadism and prostate cancer (PCa) comparing Testosterone replacement therapy with Placebo (2 arms). Primary endpoint: Primary EPIC-26 sexual domain score at 12 months. Started Aug 2020; status: active.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadismprostate cancer (PCa)
Beyond the preview
Go deeper on 2020-003012-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003012-27.